Yeast-Produced S1 Recombinant Protein of SARS-CoV-2
-
Published:2022-12-01
Issue:2
Volume:9
Page:37-41
-
ISSN:1727-3706
-
Container-title:Vaccine Research
-
language:en
-
Short-container-title:vacres
Author:
Majidi SanazORCID,
Aghaeipour KhosrowORCID,
Abedi Kiasari BahmannORCID,
Akrami MeisamORCID,
Mohammadi AshrafORCID,
Najafi HamidehORCID,
Mousavi Fatemeh Sadat
Publisher
Apex Publishing
Reference33 articles.
1. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The lancet. 2020;395(10229):1054-62.
2. Hu Z, Chen J-P, Xu J-C, Chen Z-Y, Qu R, Zhang L et al. A two-dose optimum for recombinant S1 protein-based COVID-19 vaccination. Virology. 2022;566:56-9.
3. Coronavirus WN. Situation Report–11. 2020. 2019.
4. Omidi M, Maher A, Etesaminia S. Lessons to be learned from the prevalence of Covid-19 in Iran. Medical Journal of the Islamic Republic of Iran. 2020;34:54.
5. Wu D, Wu T, Liu Q, Yang Z. The SARS-CoV-2 outbreak: what we know. International journal of infectious diseases. 2020;94:44-8.